Physician profile
John Andrews
NPI 1427146497
$816.06
in general payments reported to CMS, 2019-2025
7 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.54 · 2021: $132 · 2023: $357 · 2024: $171 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $270.75 | 2021-2025 | Caplyta |
| Supernus Pharmaceuticals, INC. | $243.37 | 2023-2025 | Qelbree, Qelbree |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Abbvie INC. | $108.46 | 2021-2023 | Vraylar |
| Axsome Therapeutics, INC. | $27.13 | 2024 | Auvelity |
| Allergan, INC. | $21.54 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $19.81 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.